Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

merger acquisition M&A business

Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

the words "FDA recall" on a board

FDA recalls Zyno infusion pumps, citing risk of death

Some infusion systems manufactured by Zyno Medical were released with unapproved software that could cause safety features to malfunction. Use of any device subject to the recall is to cease immediately. 

money maze payment reimbursement

Why more doctors should pursue business and leadership training

“Just as medicine has its own language, so does business," two surgeons explained in a new editorial. 

Inquis Medical Aventus Thrombectomy System

FDA clears blood clot removal system for treating pulmonary embolism

The Aventus Thrombectomy System was already cleared to treat blood clots in the peripheral arteries. This latest approval comes after positive results from an IDE study were published in JSCAI.

Next-day discharge after TAVR is still safe when alternative access is required

Even TAVR patients not treated using transfemoral access can typically go home the very next day. 

Thumbnail

Signs of Alzheimer's evident on imaging up to 15 years prior to symptom onset in Down syndrome population

By identifying these structural changes prior to the onset of symptomatic neurodegeneration, providers may be able to initiate preventive therapies sooner.

Hemal Gada, MD, cardiologist

Q&A: Cardiologist and EARLY TAVR co-author questions study’s execution

The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of asymptomatic patients. However, one cardiologist who participated in the trial has some serious concerns with how its findings were presented to the public. 

business launch

Medtronic’s diabetes spin-off gets a name, kicking off ‘new and exciting chapter’

The new name will be familiar to anyone who knows the history of Medtronic's diabetes business.